DLL4
- CAS No.
- Chemical Name:
- DLL4
- Synonyms
- AOS6;DLL4;UNQ1895;PRO4341;hdelta2;Human DLL4 Protein, Fc Tag;Human DLL4 Protein, His Tag
- CBNumber:
- CB75117449
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
DLL4 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 560499 | DLL4 PurifiedbyProteinGaffinitychromatography. | 50ug | $509 | 2026-06-03 | Buy | |
| Usbiological | 560499 | DLL4 PurifiedbyProteinGaffinitychromatography. | 100ug | $708 | 2026-06-03 | Buy | |
| Usbiological | 522294 | DLL4 Purifiedbyaffinitychromatography. | 100ul | $758 | 2026-06-03 | Buy | |
| Usbiological | 522294 | DLL4 Purifiedbyaffinitychromatography. | 200ul | $984 | 2026-06-03 | Buy | |
| Usbiological | 501544 | DLL4 PurifiedbyProteinAandpeptideaffinitychromatography. | 200ul | $772 | 2026-06-03 | Buy |
DLL4 Chemical Properties, Uses, Production
Description
The Notch pathway has been identified as one of the most commonly activated
pathways in cancer. This signaling cascade is crucial for cell growth, differentiation, and survival. Notch signaling has been identified as possibly having an impact in survival in those who have a diagnosis of cancer and thus
makes this a pathway of interest.
The Notch pathway is activated when a Notch receptor binds to a ligand. The
mammalian Notch family contains five ligands, delta-like ligand 1 (DLL1), deltalike ligand 3 (DLL3), delta-like ligand 4 (DLL4), Jagged-1 (JAG1), and Jagged-2
(JAG2), and four receptors, Notches 1–4. For the purpose of this review, we will
focus on DLL4, which has been studied in SCLC and implicated in activating NF-κβ
leading to enhanced VEGF secretion and promotion of metastases.
Pharmacology
During tumorigenesis, induction of DLL4 expression by VEGF in endothelial cells of the tumor leads to improved angiogenesis. Interruption of DLL4-Notch signaling led to suppression of tumor growth via nonproductive angiogenesis and hypoxia of tumors. High levels of DLL4 are expressed in cancer stem cells in preclinical models using SCLC cell lines. In human tumor xenografts, targeting DLL4-Notch with anti-DLL4 monoclonal antibodies as a single agent or in combination with cisplatin/etoposide or topotecan resulted in reduction of cancer stem cells.
DLL4 Preparation Products And Raw materials
Raw materials
Preparation Products
DLL4 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Shanghai Huzhen Industrial Co., LTD | 021-60345367 13916550749 | sales@shzbio.com | China | 9965 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| ACROBiosystems | 13121935750 | jiaxin.zhao@acrobiosystems.com | China | 1582 | 58 |
| Shanghai Yubo Biotechnology Co., Ltd | 021-60514606 18321282235 | sale1@shybsw.net | China | 8165 | 58 |
| shlmai | 021-67680335 13052188602 | sale1@shlmai.net | China | 10000 | 58 |
| Supplier | Advantage |
|---|---|
| Wuhan Chemstan Biotechnology Co., Ltd. | 58 |
| Shanghai Huzhen Industrial Co., LTD | 58 |
| Biolab Reagents | 58 |
| ACROBiosystems | 58 |
| Shanghai Yubo Biotechnology Co., Ltd | 58 |
| shlmai | 58 |
